A diagnostic ‘cocktail,’ containing a single drop of blood, a dribble of water and a dose of DNA powder with gold particles, could one day lead to the treatment of the world’s leading diseases.
This homegrown brew is being developed by IBBME PhD student Kyryl Zagorovsky and Professor Warren Chan (IBBME), a Canada Research Chair in Nanobiotechnology, and a recent winner of the NSERC E.W.R. Steacie Memorial Fellowship.
“There’s been a lot of emphasis in developing simple diagnostics,” said Professor Chan. “The question is, how do you make it simple enough, portable enough?”
Professor Chan’s lab studies nanoparticles – in particular, the use of gold particles in sizes so small that they are measured in the nanoscale. He and his group are working on custom-designing nanoparticles to target and illuminate cancer cells and tumours, with the potential of one day being able to deliver drugs to cancer cells.
Zagorovsky’s rapid-diagnostic biosensor will allow technicians to test for multiple diseases at one time with one small sample, and with high accuracy and sensitivity. The biosensor relies upon gold particles in much the same vein as your average pregnancy test. With a pregnancy test, gold particles turn the test window red because the particles are linked with an antigen that detects a certain hormone in the urine of a pregnant woman.
“Gold is the best medium,” explained Professor Chan, “because it’s easy to see. It emits a very intense colour.”
Currently, scientists can target a particular disease by linking gold particles with DNA strands. When a sample containing the disease gene (e.g., Malaria) is present, it clumps the gold particles, turning the sample blue.
Rather than clumping the particles together, Zagorovsky immerses the gold particles in a DNA-based enzyme solution (DNA-zyme) that, when the disease gene is introduced, ‘snip’ the DNA from the gold particles, turning the sample red.
“It’s like a pair of scissors,” said Zagorovsky. “The target gene activates the scissors that cut the DNA links holding gold particles together.”
The advantage is that far less of the gene needs to be present for the solution to show noticeable colour changes, amplifying detection. A single DNA-zyme can clip up to 600 ‘links’ between the target genes.
Just a single drop from a biological sample such as saliva or blood can potentially be tested in parallel, so that multiple diseases can be tested in one sitting.
The Latest Bing News on:
Rapid-diagnostic biosensor
- Rapid Growth Forecasted: Glucose Oxidase Market to Witness 6.4% CAGR, Reaching USD 12.04 Billion by 2023on May 8, 2024 at 8:56 pm
Glucose Oxidase Market The market for glucose oxidase is on a trajectory of significant growth, with an anticipated valuation of US$ 12.04 billion by 2023, marking a substantial increase from US$ 6.54 ...
- Rapid City, SDon May 6, 2024 at 4:59 pm
Rapid City also has a large amount of public sculpture on display in many parts of the city. The most visible is The City of Presidents, a series of life-sized bronze statues representing each of ...
- Biosensors Market Size To Touch USD 52.93 Billion, Rising At A CAGR Of 7.9% By 2030: SNS Insideron May 5, 2024 at 6:03 am
( MENAFN - Evertise Digital) - The Biosensors Market , valued at USD 28.80 billion in 2022, is forecasted to reach USD 52.93 billion by 2030, growing at a CAGR of 7.9% from 2023 to 2030.
- Access Bio Inc Korean Depository Receipts 950130on May 2, 2024 at 5:00 pm
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
- How Accurate Are Rapid Influenza Diagnostic Tests?on May 2, 2024 at 5:00 pm
Accuracy of rapid influenza diagnostic tests: data from a meta-analysis of 159 diagnostic accuracy studies (from 119 articles). Hierarchical summary receiver-operating characteristic curve plot.
- UGA researchers developer "faster and more reliable" COVID teston April 5, 2024 at 1:31 am
In a new study published in Advanced Materials Interface, the UGA research team describes the rapid diagnostic test for SARS-CoV-2 detection and quantification directly from human nasopharyngeal ...
- Affinity Biosensors Receives FDA Clearance for the LifeScale AST Systemon April 4, 2024 at 7:53 am
Key features of the LifeScale AST system include: Rapid results ... Affinity Biosensors was founded in 2006 to develop advanced instrumentation for life science and diagnostic applications.
- Affinity Biosensors Receives FDA Clearance for the LifeScale AST Systemon April 3, 2024 at 4:20 pm
April 3, 2024 /PRNewswire/ -- Affinity Biosensors, a leading innovator in the field of healthcare diagnostics ... benchtop system that performs rapid phenotypic antibiotic susceptibility tests ...
- CRISPR/Cas-Enabled Paper Microfluidics Device for Rapid Diagnosison March 26, 2024 at 12:00 am
Here we present a low-cost, deployable paper-based biosensor device for rapid analysis of pathogens for a wide range of application including rapid diagnosis of infectious disease (such as SARS-CoV-2) ...
- Advancing Rapid Point-of-care Viral Diagnostics to a Clinical Settingon April 28, 2015 at 9:12 pm
We discuss here critical factors in ensuring the success of a viral diagnostic at the point of ... particularly in the developing world. Rapid immunoassays are widely used in POC testing because ...
The Latest Google Headlines on:
Rapid-diagnostic biosensor
[google_news title=”” keyword=”rapid-diagnostic biosensor” num_posts=”10″ blurb_length=”0″ show_thumb=”left”] [/vc_column_text]The Latest Bing News on:
Multiple disease testing
- Health practice suspended after lung testing auditon May 8, 2024 at 8:36 pm
More than 130 coal miners will need to have their lungs retested after an audit found some tests didn't meet minimum standards.
- DHEC Encourages Hepatitis C Testing During Hepatitis Awareness Monthon May 8, 2024 at 8:06 am
May is National Hepatitis Awareness Month, and the South Carolina Department of Health and Environmental Control is encouraging South Carolinians to know their status and get tested.
- Assessing Peripheral Neuropathy Role in Acupuncture for Managing Multiple Myelomaon May 8, 2024 at 1:04 am
The following is a summary of "Acupuncture in Multiple Myeloma Peripheral Neuropathy: A Systematic Review," published in the April 2024 issue of Pain by Lyu et al. Though a common complication of ...
- Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024on May 7, 2024 at 4:22 am
About Lenmeldy Lenmeldy™ (atidarsagene autotemcel), formerly known as OTL-200, is the only approved therapy in the U.S. for the treatment of children with pre-symptomatic late infantile (PSLI), ...
- FDA Over-Regulation of Lab Tests Could Harm Patientson May 6, 2024 at 6:23 am
Requiring FDA approval for laboratory developed tests would be an overreaction to the Theranos debacle and would ultimately harm patients ...
- Testing for residual cancer cells before blood cell transplant therapy is important and practical, new study findson May 1, 2024 at 5:00 pm
Patients with a type of high-risk blood cancer are likely to do better if no trace of the cancer is detectable before they receive donor blood cells. The finding in JAMA Oncology emphasizes the ...
- Agriculture Department testing beef for bird flu viruson April 30, 2024 at 10:56 am
The Department of Agriculture (USDA) is testing beef for a bird flu virus following the infections of cattle in multiple states, though it says it remains confident the country’s meat supply ...
- Multiple sclerosis discovery could be a breakthroughon April 29, 2024 at 5:00 pm
We’ve made significant progress in developing better treatments for multiple sclerosis over the past ... a path to studying the very earliest stages of the disease — work that could lead to better ...
- Lisa Jarvis: This multiple sclerosis discovery could be a breakthroughon April 29, 2024 at 10:43 am
We’ve made significant progress in developing better treatments for multiple sclerosis over the last two decades. Yet the medical community still struggles to diagnose the neurological condition, let ...
- Blood test might someday diagnose early MSon April 27, 2024 at 6:10 am
An early marker of multiple sclerosis could help doctors figure out who will eventually fall prey to the degenerative nerve disease, a new study says.
The Latest Google Headlines on:
Multiple disease testing
[google_news title=”” keyword=”multiple disease testing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]